Katherine Scangos, M.D. (left), oversees transcranial magnetic stimulation. Credit: TMS and Neuromodulation Program/UC San Francisco Some 30 to 40% of patients do not respond to medications for depression and obsessive-compulsive disorder (OCD), but half of them could be helped by a noninvasive in-office procedure. To mark National Mental Health Awareness Month in May, we talk to psychiatrist Katherine Scangos, M.D., Ph.D., co-director of the Transcranial Magnetic Stimulation (TMS) and Neuromodulation Program at UC San Francisco. TMS is a logical next step for many patients with an inadequate response to standard Read More
HEALTH DAILY NEWS
Health News, Medical News, Medical conditions, Medical Tests & Procedures, Symptoms, Medical Diagnosis , Health Information, FDA alerts, Drug Watch, Product Watch, Medicine Articles, Welfare, Living